STOCK TITAN
MARKET LEADERS
#1 JANX leads with +470% February 2024

JANX (Janux Therapeutics, Inc.) is the best performing stock in February 2024. Following are STI (+334%) and SOUN (+334%). Top performing sectors: Financial Services (+107% avg, 2 in top 10), Real Estate (+94% avg), Industrials (+93% avg, 1 in top 10).

Top Stock Gainers February 2024 - Monthly Performance Ranked

Track the top performing stocks of February 2024 ranked by monthly price gain. See which stock gainers delivered the highest gains this month, with market caps over $100 million on Nasdaq and NYSE.
2024

This ranking shows the top performing stocks and biggest stock gainers during February 2024, calculated from the first to the last trading day of the month. It shows which stocks are going up this month, with split-adjusted data used for consistent performance calculations.

Monthly performance rankings can reveal price strength, sustained momentum, sector rotation, and event-driven moves that are not visible in one-day movers lists. The table is informational only and does not recommend any stock to buy, sell, or hold.

February 2024 Stock Market Momentum

This page answers a current-month trend question with data: which NYSE and NASDAQ stocks have shown the strongest price gains so far in February 2024. The ranking is based on observed market performance, not analyst ratings, price targets, or investment recommendations.

Use the list to research momentum, market breadth, sector strength, and catalysts behind large moves. Before acting on any stock, review the company's news, SEC filings, liquidity, volatility, and your own risk constraints.

Looking for a specific Symbol?

Data as of June 23, 2026 at 2:50 PM EDT

Rank
Symbol
Company Name
Feb Gain
Market Cap
Price
Country
Sector
1
469.85%
874.52 M
$ 14.34
United States
Healthcare
2
334.29%
128.79 M
$ 15.16
United States
Industrials
3
333.92%
2.98 B
$ 6.88
United States
Technology
4
291.59%
808.25 M
$ 51.07
United States
Financial Services
5
221.71%
3.76 B
$ 32.37
United States
Healthcare
6
216.07%
1.00 B
$ 14
United States
Healthcare
7
203.66%
180.83 M
$ 2.86
United States
Healthcare
8
177.01%
319.84 M
$ 6.77
United States
Technology
9
173.93%
509.18 M
$ 2.72
Hong Kong
Financial Services
10
155.12%
245.42 M
$ 4.18
United States
Healthcare
11
123.9%
459.96 M
$ 68.66
United States
Healthcare
12
114.25%
402.99 M
$ 1.69
China
Consumer Defensive
13
110.43%
133.60 M
$ 33.92
United States
Healthcare
14
110.07%
2.51 B
$ 17.71
United States
Healthcare
15
110.05%
1.65 B
$ 55.42
United States
Healthcare
16
103.68%
817.43 M
$ 6.6
Germany
Consumer Cyclical
17
103.64%
1.83 B
$ 3.83
United States
Technology
18
103.15%
39.16 B
$ 109.46
United States
Technology
19
102.56%
1.88 B
$ 6.53
United States
Healthcare
20
101.81%
112.74 M
$ 1.62
Israel
Healthcare
21
101.09%
9.06 B
$ 24.47
United States
Technology
22
100%
4.48 B
$ 17.45
United States
Financial Services
23
100%
435.48 B
$ 407.72
United Kingdom
Technology
24
99.56%
301.78 M
$ 3.1
United States
Industrials
25
99.43%
191.11 M
$ 1.99
United States
Industrials
26
99.04%
281.49 M
$ 7.36
United States
Technology
27
97.39%
1.81 B
$ 4.06
United States
Healthcare
28
97.37%
101.20 M
$ 2.77
United States
Technology
29
95.76%
405.03 M
$ 7.85
United States
Healthcare
30
94.64%
119.56 M
$ 0.855
United States
Technology
31
93.57%
5.58 B
$ 26.31
United States
Real Estate
32
92.58%
24.95 B
$ 2.68
Sweden
Consumer Cyclical
33
91.67%
380.21 M
$ 3.66
United States
Healthcare
34
91.62%
2.18 B
$ 9.97
United States
Healthcare
35
89.97%
455.54 M
$ 4.12
United States
Healthcare
36
89.08%
112.20 M
$ 1.42
United States
Communication Services
37
81.99%
7.13 B
$ 103.17
United States
Technology
38
78.53%
73.13 B
$ 66.67
United States
Consumer Cyclical
39
76.6%
436.69 M
$ 1.29
United States
Healthcare
40
74.77%
166.67 M
$ 0.9451
United States
Financial Services
41
74.76%
113.21 M
$ 1.69
Canada
Healthcare
42
73.11%
122.19 M
$ 1.06
Canada
Healthcare
43
72.96%
373.38 M
$ 13.3
United States
Technology
44
72.32%
422.56 M
$ 12.3
United States
Healthcare
45
72.21%
935.06 M
$ 3.36
United States
Healthcare
46
71.43%
231.00 M
$ 4.11
United States
Healthcare
47
71.43%
134.95 M
$ 2.13
United States
Healthcare
48
70.8%
668.55 M
$ 17.27
United States
Industrials
49
70.24%
6.05 B
$ 92.44
United States
Technology
50
69.04%
1.68 B
$ 8.53
United States
Healthcare
51
68.48%
215.42 M
$ 2.37
United States
Healthcare
52
66.97%
1.31 B
$ 7.37
United States
Consumer Cyclical
53
66.67%
495.91 M
$ 5.15
United States
Healthcare
54
63.41%
3.53 B
$ 21.99
United States
Industrials
55
62.69%
450.55 M
$ 18.19
United States
Technology
56
62.28%
182.68 M
$ 7.08
United States
Healthcare
57
60.66%
852.59 M
$ 10.69
United States
Healthcare
58
60.48%
550.35 M
$ 10.18
United States
Communication Services
59
60.47%
327.72 M
$ 5.75
United States
Healthcare
60
60.34%
458.55 M
$ 16.52
United Kingdom
Technology
61
60.13%
661.82 M
$ 3.04
United States
Healthcare
62
59.79%
359.86 M
$ 0.6983
United States
Consumer Defensive
63
59.73%
7.44 B
$ 29.12
United States
Consumer Defensive
64
59.69%
11.21 B
$ 307.8
United States
Industrials
65
58.53%
372.76 M
$ 21.42
United Kingdom
Technology
66
58.53%
447.65 M
$ 9.845
Luxembourg
Consumer Cyclical
67
58.28%
1.93 B
$ 30.97
United States
Healthcare
68
57.98%
822.26 M
$ 2.14
United States
Technology
69
57.86%
43.43 B
$ 164.84
United States
Financial Services
70
57.84%
279.31 M
$ 11.97
United States
Healthcare
71
57.58%
274.70 M
$ 23.66
United States
Healthcare
72
57.39%
12.87 B
$ 12.82
China
Consumer Cyclical
73
57.33%
20.32 B
$ 56.87
Australia
Financial Services
74
56.25%
6.12 B
$ 35.84
United States
Healthcare
75
56.11%
546.93 M
$ 4.94
China
Communication Services
76
54.82%
3.33 B
$ 26.66
United States
Healthcare
77
53.65%
1.79 B
$ 30.14
United States
Healthcare
78
53.58%
286.48 B
$ 119.5
United States
Technology
79
52.71%
527.93 M
$ 6.37
United States
Industrials
80
52.14%
972.10 M
$ 9.96
United States
Industrials
81
52.1%
994.04 M
$ 11.13
United States
Healthcare
82
51.74%
1.21 B
$ 33.32
United States
Technology
83
51.56%
671.21 M
$ 25.78
United States
Financial Services
84
51.53%
1.93 B
$ 18.65
United States
Healthcare
85
50.94%
317.95 M
$ 38.4
United States
Healthcare
86
50.83%
1.49 B
$ 20.79
United States
Consumer Cyclical
87
50.74%
221.35 M
$ 12.94
United States
Healthcare
88
50.68%
104.65 M
$ 0.4855
Australia
Industrials
89
50.08%
544.72 M
$ 10.42
United States
Healthcare
90
49.5%
95.19 B
$ 105.71
United States
Financial Services
91
49.41%
3.66 B
$ 35.53
United States
Healthcare
92
48.81%
594.78 M
$ 6.13
United States
Healthcare
93
48.75%
11.13 B
$ 30.99
United States
Technology
94
48.44%
22.94 B
$ 35.46
United States
Technology
95
48.18%
1.41 B
$ 9.7
United States
Technology
96
48.08%
434.33 M
$ 7.88
United States
Basic Materials
97
48.05%
3.51 B
$ 9.205
United States
Healthcare
98
47.11%
2.17 B
$ 19.18
United States
Healthcare
99
46.67%
107.53 M
$ 1.41
Japan
Technology
100
46.51%
127.04 M
$ 5.6
United States
Industrials
For the most accurate results, consider cross-referencing our data with other sources.

Frequently Asked Questions

Q Which stock has gained the most in February 2024?
A

JANX (Janux Therapeutics, Inc.) has the highest monthly gain in this ranking for February 2024, with a gain of 470%. Top performers this month include JANX, STI, SOUN.

Q What stocks gained the most in February 2024?
A

The biggest gainers in February 2024 were: JANX (+470%), STI (+334%), SOUN (+334%), ROOT (+292%), VKTX (+222%). These monthly rankings show which stocks had the strongest short-term momentum.

Q Does this page recommend the best stocks to buy now?
A

No. This page is an informational ranking of stocks that have already gone up during February 2024. It does not make buy, sell, or hold recommendations and should be used as a research starting point, not financial advice.

Q How can this ranking help explain current stock market trends?
A

The ranking shows where price strength is concentrated during February 2024. Comparing the top gainers by sector, market cap, and recent catalysts can help identify momentum themes and market rotation without implying that any listed stock is a recommendation.

Q Which sectors performed best in February 2024?
A

The top performing sectors in February 2024 included Healthcare, Industrials, Technology, based on the stocks with highest monthly gains. JANX led the Healthcare sector.

Q How is monthly stock performance calculated?
A

Monthly stock performance is calculated by comparing the closing price on the last trading day of the month to the opening price on the first trading day. Split-adjusted prices ensure accuracy.

Q Where can I find today's top stock gainers and most active stocks?
A

This page ranks stocks by their full-month performance in February 2024. For today's top stock gainers, real-time stock movers, and the most active stocks right now, visit our Momentum Scanner which tracks live intraday market activity across NYSE and NASDAQ.

Understanding Monthly Stock Performance

Monthly performance rankings reveal short-term momentum patterns and help identify stocks experiencing rapid price movements:

  • Momentum Research: Stocks showing strong monthly performance can help identify where market attention and price strength are concentrated.
  • Sector Rotation: Monthly rankings can reveal which sectors are gaining favor with investors and where market leadership is shifting.
  • Event-Driven Moves: Earnings releases, product launches, and regulatory approvals often create significant monthly price movements.

Using Monthly Data Effectively

  • Combine Timeframes: Compare monthly gainers with 52-week and YTD performance to identify stocks with both short and long-term momentum.
  • Research the Catalyst: Investigate why top monthly performers moved significantly. The reason for the move matters as much as the percentage gain.
  • Watch for Reversals: Extreme monthly gains sometimes precede corrections, so treat the ranking as a research starting point rather than a buy list.

Evaluate Your Positions

Researching one of this month's top movers? Use our Stock Return Calculator to review historical performance, or the Position Size Calculator to model position sizing and risk before making your own decision.